about
Herpes simplex virus and varicella zoster virus, the house guests who never leaveMolecular mechanisms of varicella zoster virus pathogenesis.Prospects and perspectives for development of a vaccine against herpes simplex virus infections.Differential apoptosis gene expressions of rhabdomyosarcoma cells in response to enterovirus 71 infection.Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.Varicella-zoster virus inhibition of the NF-κB pathway during infection of human dendritic cells: role for open reading frame 61 as a modulator of NF-κB activityImmune correlates of herpes zoster in HIV-infected children and youth.Functional flexibility of intestinal IgA - broadening the fine line.Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) VaccinationCD4 T cell responses in latent and chronic viral infections.Eye and Periocular Skin Involvement in Herpes Zoster InfectionImmunity to bovine herpesvirus 1: I. Viral lifecycle and innate immunity.Metabolic Phenotypes of Response to Vaccination in Humans.Immunological evasion of immediate-early varicella zoster virus proteins.Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia.Decreased absolute numbers of CD3+ T cells and CD8+ T cells during aging in herpes zoster patients.In vivo confocal microscopy detects bilateral changes of corneal immune cells and nerves in unilateral herpes zoster ophthalmicus.Tunneling Nanotubes as a Novel Route of Cell-to-Cell Spread of Herpesviruses.Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged ≥50 Years.
P2860
Q21195896-24CCC1BC-E488-45BF-8E6C-76EF0FACF181Q33791387-1DAF3C28-9113-4020-AD2B-FB79D3E3CB69Q34431547-303B30EA-5C22-4D7B-9E2B-47920CF9C5C4Q34494794-DB781D8E-4B24-40DC-B2E0-B3D9471AA699Q35133349-3B998A01-D29B-46C4-A314-89EEA24AA574Q35665805-708067D2-3A0F-4B1F-B296-09DA0374FCD6Q35826138-CA959C91-70FB-4F58-80B2-1C5754D9D353Q35929062-AF9D28E0-E9F4-4EAE-BA95-BA05E3CF81DAQ36237622-4CA33DB1-06F2-4C47-B5C6-9E73AE94A6DCQ36837631-170E932E-1611-4D84-9594-1B4E4672C245Q37380047-E0628DCC-69E9-4B0E-8F12-1D2520B1A733Q38116992-5E14A112-FE27-4B3E-A2E6-7C6F6AD0351CQ40202000-DB9E19BB-EFE9-4C8F-A426-352BD1458680Q40738841-E6406A92-87DA-4E83-AB9A-3EAF06D3FAFEQ41684668-FB6905D0-7481-466D-9025-C31567DE56F5Q47136517-6CAA76EE-D183-4845-9EE3-369AB2BFD998Q50038511-FA858163-8227-448B-BB69-02A20A99EAE8Q52680798-EE34FF7E-A045-419E-93F7-FE8B70F819DAQ52727148-02A70605-7B19-4D73-816D-C0354043F006
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Varicella zoster virus immune evasion strategies.
@en
Varicella zoster virus immune evasion strategies.
@nl
type
label
Varicella zoster virus immune evasion strategies.
@en
Varicella zoster virus immune evasion strategies.
@nl
prefLabel
Varicella zoster virus immune evasion strategies.
@en
Varicella zoster virus immune evasion strategies.
@nl
P2860
P356
P1476
Varicella zoster virus immune evasion strategies
@en
P2093
Allison Abendroth
Paul R Kinchington
P2860
P304
P356
10.1007/82_2010_41
P577
2010-01-01T00:00:00Z